FORMULATION, CHARACTERIZATION, AND IN VITRO TOXICITY TEST OF LIPID NANOPARTICLE DOSAGE FORM FOR SIMVASTATIN DRUG DELIVERY
Simvastatin is one of the first line therapy for hypercholesterolemia. Therapy for lowering cholesterol levels in general is still done through oral route which has many weaknesses. Drug delivery system using lipid nanoparticles (LNP) could potentially be a new innovation for therapy using sta...
Saved in:
Main Author: | Ricardo Setiadi, Anfield |
---|---|
Format: | Final Project |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/78390 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Similar Items
-
SOLID LIPID NANOPARTICLE DEVELOPMENT FORMULATION TRANSDERMAL DOSAGE FORM OF FUROSEMIDE AND IN VITRO TESTING
by: Forestryana, Dyera -
ANTIHYPERCHOLESTEROLEMIA ACTIVITY STUDY OF SIMVASTATIN WITH LIPID NANOPARTICLES (LNP) AS DRUG DELIVERY SYSTEM IN HEPG2 CELLS
by: Rula Akifah, Latisha -
ANTIHYPERCHOLESTEROLEMIA ACTIVITY STUDY OF SIMVASTATIN WITH LIPID NANOPARTICLES (LNP) AS DRUG DELIVERY SYSTEM IN HEPG2 CELLS
by: Rula Akifah, Latisha -
Towards sustainable preparation of oral solid dosage form of drug nanoparticles
by: Jia, Tong
Published: (2013) -
FORMULATION AND EVALUATION OF NANOSTRUCTURED LIPID CARRIER FROM POMEGRANATE PEEL EXTRACT (PUNICA GRANATUM L.) AND ITS ANTIWRINKLE ACTIVITY TEST IN CREAM DOSAGE FORM
by: Diantinofriani